CI vs GNLX · P/E 2.4, rev $140.16B vs rev $8.0K
Cigna Corp (CI) versus Genelux Corporation Common Stock (GNLX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
Latest reported CI revenue for 2026-06-30 was $140.16B. Net income was $3.31B. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. GNLX currently screens at market cap $130.6M.
Not investment advice. Open the CI and GNLX stock pages for the full models.
Not investment advice.